Molndal, Sweden

Annika Astrand

This inventor holds 1 USPTO granted patent. Top assignee: Dizal (Jiangsu) Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annika Astrand. Retrieved from https://idiyas.com/inventor/annika-astrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annika Astrand: Innovator in Pharmaceutical Science

Introduction

Annika Astrand is a notable inventor based in Molndal, Sweden. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds for treating JAK-related disorders.

Latest Patents

Annika holds 1 patent for her work titled "Compounds and methods for inhibiting JAK." This patent discloses compounds of formula (I), pharmaceutical compositions comprising such compounds, and methods for using them to treat conditions such as cancer, cancer cachexia, or immune disorders.

Career Highlights

Annika is currently employed at Dizal (Jiangsu) Pharmaceutical Co., Ltd., where she continues to innovate and contribute to the pharmaceutical industry. Her work focuses on developing new therapeutic options for patients suffering from serious health conditions.

Collaborations

Throughout her career, Annika has collaborated with esteemed colleagues, including Neil Patrick Grimster and Sameer Pralhad Kawatkar. These partnerships have enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Annika Astrand's contributions to pharmaceutical science exemplify her dedication to innovation and improving patient outcomes. Her work in developing JAK inhibitors is a testament to her expertise and commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…